J Reconstr Microsurg 2004; 20(1): 53-58
DOI: 10.1055/s-2004-818050
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA

Effects of Vascular Endothelial Growth Factor on Nerve Regeneration in Acellular Nerve Grafts

Jason M. Rovak1 , Anil K. Mungara2 , Mustafa A. Aydin3 , Paul S. Cederna2 , 4
  • 1Duke University Medical School, Durham, NC
  • 2Section of Plastic and Reconstructive Surgery, University of Michigan, Ann Arbor, MI
  • 3Department of Plastic Surgery, Suleyman Demirel University, Isparta, Turkey
  • 4Institute of Gerontology, University of Michigan, Ann Arbor, MI
Further Information

Publication History

accepted: September 4, 2003

Publication Date:
18 February 2004 (online)

The purpose of this study was to evaluate the effects of human recombinant vascular endothelial growth factor (VEGF-165) on peripheral nerve axonal sprouting and elongation following peripheral nerve injury and repair. Two-centimeter nerve gaps were created in rat peroneal nerves and repaired with either peripheral nerve autografts, acellular peripheral nerve isografts, or VEGF-165-treated acellular peripheral nerve isografts. Four months postoperatively, the peroneal nerves were harvested and histomorphometric analysis was performed. The reinnervated extensor digitorum longus (EDL) muscles were harvested and weighed.

At the proximal nerve gap coaptation site, there was a statistically significant increase in the total number of axons and percent neural tissue in the VEGF-treated acellular nerve graft group, compared with the acellular peripheral nerve isograft and autograft groups. At the distal coaptation site, however, the total number of axons and percent neural tissue was similar in the acellular and VEGF-treated groups, which was significantly less than the autograft group. VEGF-165 treatment of acellular nerve grafts resulted in greater EDL muscle masses than acellular nerve grafts alone.

VEGF treatment of acellular peripheral nerve isografts enhances axonal sprouting, resulting in an increased number of axons and percent neural tissue at the proximal nerve graft coaptation site. In the absence of any cellular elements, VEGF-impregnated acellular peripheral nerve grafts do not demonstrate enhanced axonal elongation, as noted by relatively few axons at the distal nerve graft coaptation site.

REFERENCES

  • 1 Evans P J, Midha R, Mackinnon S E. The peripheral nerve allograft: a comprehensive review of regeneration and neuroimmunology.  Progr Neurobiol. 1994;  43 187-233
  • 2 Brunelli G, Vigasio A, Brunelli G. Different conduits in peripheral nerve surgery.  Microsurgery. 1994;  15 176-178
  • 3 Lundborg G, Dahlin L, Danielsen N, et al.. Nerve regeneration in silicone model chambers: influence of gap length and of distal stump components.  Exp Neurol. 1982;  76 361-375
  • 4 Dumont C, Hentz V. Enhancement of axonal growth by detergent-extracted nerve grafts.  Transplantation. 1997;  63 1210-1215
  • 5 Sondell M, Lundborg G, Kanje M. Regeneration of the rat sciatic nerve into allografts made acellular through chemical extraction.  Brain Res. 1998;  795 44-54
  • 6 Haase S C, Cederna P S, Dennis R G, Kuzon W M. Peripheral nerve repair using acellular nerve grafts.  Surgical Forum. 2000;  51 607-609
  • 7 Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts.  Brain Res. 1999;  846 219-228
  • 8 Hobson M, Green C, Terenghi G. VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy.  J Anat. 2000;  197 591-605
  • 9 Maciag T, Cerundolo J, Ilsley S, et al.. An endothelial cell growth factor from bovine hypothalamus: identification and partial characterization.  Proc Natl Acad Sci USA. 1979;  76 5674-5678
  • 10 Meirer R, Gurunluoglu R, Siemionow M. Neurogenic perspective on vascular endothelial growth factor: review of the literature.  J Reconstr Microsurg. 2001;  17 625-629
  • 11 Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system.  J Neurosci. 1999;  19 5731-5740
  • 12 Dennis R G, Kuzon W M, Cederna P S. US patent #6448076. Method for chemically acellularizing a biological tissue sample, 2002. 
  • 13 Kramer H, Windrum G M. The metachromatic staining reaction.  J Histochem. 1995;  3 227-231
  • 14 Sondell M, Kanje M. Postnatal expression of VEGF and its receptor flk-1 in peripheral ganglia.  Neuroreport. 2001;  12 105-108
  • 15 Ferrara N, Carver-Moore K, Chen H, et al.. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene.  Nature. 1996;  380 439-442
  • 16 Kawasaki T, Kitsukawa T, Bekku Y, et al.. Requirement for neurophilin-1 in embryonic vessel formation.  Development. 1999;  126 4895-4902
  • 17 Smith M, Browne D. The effect of endothelial cell growth factor on peripheral nerve regeneration.  Otolaryngol Head Neck Surg. 1998;  118 178-182
  • 18 Gulati A, Cole G. Nerve graft immunogenecity as a factor determining axonal regeneration in the rat.  J Neurosurg. 1990;  72 114-122
  • 19 Sondell M, Sundler F, Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor.  Eur J Neurosci. 2000;  12 4243-4254
  • 20 Hoke A, Sun H S, Gordon T, Zochodne D W. Do denervated peripheral nerve trunks become ischemic? The impact of chronic denervation on vasa nervorum.  Exper Neurol. 2001;  172 398-406
  • 21 Simovic D, Isner J M, Ropper A H, et al.. Improvement in chronic ischemic neuropathy after intramuscular ph VEGF 165 gene transfer in patients with critical limb ischemia.  Arch Neurol. 2001;  58 761-768
  • 22 Samii A, Unger J, Lange W. Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats.  Neurosci Lett. 1999;  262 159-162
  • 23 Giger R J, Urquhart E R, Gillespie S K, et al.. Neurophilin-2 is a receptor for semaphoring IV: insight into the structural basis of receptor function and specificity.  Neuron. 1998;  21 1079-1092
  • 24 Gulati A D, Rai D R, Ali A M. The influence of cultured Schwann cells on regeneration through acellular basal lamina grafts.  Brain Res. 1995;  705 118-124
  • 25 Gulati A K. Immunological fate of Schwann cell-populated acellular basal lamina nerve allografts.  Transplantation. 1995;  59 1618-1622
  • 26 Chen Z W, Wang M S. Effects of nerve growth factor on crushed sciatic nerve regeneration in rats.  Microsurgery. 1995;  16 547-551
  • 27 Fansa H, Keilhoff G, Plogmeirer K, et al.. Successful implantation of Schwann cells in acellular muscles.  J Reconstr Microsurg. 1999;  15 61-65
  • 28 Mohammad J, Shenaq J, Rabinovsky E, Shenaq S. Modulation of peripheral nerve regeneration: a tissue-engineering approach. The role of amnion tube nerve conduit across a 1-centimeter nerve gap.  Plast Reconstr Surg. 2000;  105 660-666
  • 29 Dubuisson A S, Foidart-Desalle M, Reznik M, et al.. Predegenerated nerve allografts versus fresh nerve allografts in nerve repair.  Exper Neurol. 1997;  148 378-387
  • 30 Carmeliet P, Storkebaum E. Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders.  Semin Cell Dev Biol. 2002;  13 39-53
  • 31 Hobsdon M I. Increased vascularisation enhances axonal regeneration within an acellular nerve conduit.  Ann R Coll Surg Engl. 84 47-53
  • 32 Shefner J M, Brown R H, Cole D, et al.. Effect of neurophilin ligands on motor units in mice with SOD1 ALS mutations.  Neurology. 57 1857-1861
  • 33 Wongtrakul S, Bishop A T, Friedrich P F. Vascular endothelial growth factor promotion of neoangiogenesis in conventional nerve grafts.  J Hand Surg. 2002;  27 277-285
  • 34 Neufeld G, Cohen T, Shraga N, et al.. The neurophilins: multifunctional semaphoring and VEGF receptors that modulate axon guidance and angiogenesis.  Trends Cardiovasc Med. 2002;  12 13-19

Paul S CedernaM.D. 

Section of Plastic and Reconstructive Surgery, University of Michigan Health Systems

2130 Taubman Center, 1500 East Medical Center Drive

Ann Arbor, MI 48109-0340

    >